Workers’ Compensation Co-Chair Profiled In “Esther Omoloyin: Up Close,” Business Insurance
News

Workers’ Compensation Co-Chair Profiled In “Esther Omoloyin: Up Close,” Business Insurance

February 3, 2021

Business Insurance profiled Goldberg Segalla’s Esther F. Omoloyin, a partner based in Princeton, highlighting her recent elevation to co-chair of the firm’s national Workers’ Compensation practice.

In the Q&A, Esther discusses her outlook on the practice of workers’ compensation law, claims-related challenges that employers and insurers are facing due to COVID-19, advice for young attorneys, and her goals for the new position.

“In this new role, I plan to partner with my co-chairs, Damon Gruber and Sean McKinley, to take our group to the next level,” Esther said. “They, along with respective state leaders, have done a phenomenal job of expanding Goldberg Segalla’s workers compensation group from New York into nine other states: New Jersey, Connecticut, Pennsylvania, Maryland, North Carolina, Florida, Illinois, Missouri and California. Our next steps include expanding our strength and teams in those states, and eventually developing teams in other states. My goal is to continue to grow a larger national practice that can truly meet the needs of the country’s largest employers wherever they do business and face claims.”

READ THE FULL ARTICLE HERE:

Esther Omoloyin: Up Close,” Business Insurance, January 8, 2021


MORE ABOUT GOLDBERG SEGALLA’S ESTHER F. OMOLOYIN:

Esther F. Omoloyin heads Goldberg Segalla’s workers’ compensation practice throughout New Jersey. She has a proven track record handling and litigating matters in every workers’ compensation vicinage in the state, including through trial, and she has successfully investigated and litigated numerous workers’ compensation fraud claims. Esther represents national companies, insurance carriers, third-party administrators, self-insured companies, municipalities, and boards of education in matters involving the full range of worksite accident and occupational disease claims.